Thus, Cas-3 affects neurodegenerative diseases such as AD by apoptosis and inflammation, and an increase in caspase-3, -6 and -7 when scopolamine was administered has been reported in various studies [38,41]. The gene discussed is EFS; the disease is Alzheimer disease.